Supporting the MedTech Funding Mandate
We continue to support the MedTech Funding Mandate ( MTFM ) policy , which ensures patients and the NHS benefit from clinically effective and cost saving medical technologies faster and more equitably . These innovations enable high-quality outcomes from treatments , depend on fewer resources , and can reduce theatre time and hospital stays , enabling more patients across England to be treated quickly .
Our role in supporting the adoption and spread of these products varies from brokering initial discussions between key partners , to business case development and understanding the benefits for patients and healthcare providers . Ultimately , we strive to provide support whenever it is needed , acknowledging the pressures our healthcare partners face .
14 Transforming Lives Through Innovation
There are seven medical technologies currently being supported including the XprESS multi-sinus dilation system , Thopaz +, Spectra Optia and four Benign Prostatic Enlargement treatments - Rezum , PLASMA system , UroLift and GreenLight XPS .
The Getting It Right First Time ’ s ( GIRFT ) National Specialty Report for Urology recommended that
© hxdbzxy / Shutterstock . com